• Tidsskr. Nor. Laegeforen. · Jan 2005

    Randomized Controlled Trial Comparative Study Clinical Trial

    [Buprenorphine and methadone to opiate addicts--a randomized trial].

    • Øistein Kristensen, Olav Espegren, Reidun Asland, Else Jakobsen, Øystein Lie, and Stephen Seiler.
    • Avdeling for rus- og avhengighetsbehandling, Sørlandet sykehus, 4632 Kristiansand. oistein.kristensen@sshf.no
    • Tidsskr. Nor. Laegeforen. 2005 Jan 20; 125 (2): 148-51.

    BackgroundThere are approximately 12,000 opioid dependants in Norway. Methadone-assisted treatment was approved in Norway in 1998, buprenorphine in 2000. This study compares the efficacy of methadone (n = 25) and buprenorphine (n = 25) assisted maintenance treatment in a group of long-term (> 10 years) opioid dependant.Material And MethodsAfter randomisation patients received either 16 mg sublingual buprenorphine or individually adjusted methadone (mean 106 mg, range 80 - 160) for 26 weeks, with a rehabilitation programme run in parallel.ResultsAfter 180 days, patient retention was highest in the methadone group (85 % vs. 36 %, p < 0.0005). Days in treatment were 167 vs. 114 (95 % CI for difference 53 days (26-80), p < 0.001). Positive urine test rates for opiates (20 % vs 24 %, p < 0.01) and cannabis (33 % vs 45 %, p < 0.001) were lower in the methadone group which also had lower self-reported risk behaviour and psychological distress. However, only those on buprenorphine reported significant improvement in physical health. For older, long-term opioid dependants with significant co-morbidity and unsuccessful medication-free treatment, high-dose methadone maintenance appears to be the treatment of choice. However, in cases where methadone is poorly tolerated, buprenorphine therapy may be a good alternative.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.